Hi, what are you looking for?
Jewish Business News
Search results for "Alcobra "
IPOs
– The company plans a second Phase III trial in the US for ADHD, drawing lessons from the previous Phase III trial. Alcobra...
IPOs
– The ADHD treatment developer raised $27 million in its IPO in May. – Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD) raised a gross $33 million...
IPOs
– The company raised $25 million in its IPO just five months ago. – – / By Gali Weinreb and Tali Tsipori /...
IPOs
– Alcobra held the IPO at $8 per share, raising $25 million, at a company value of $89 million, lower than the $10-12 per...
World News
Two entrepreneurs from Baqa al-Gharbiya are building an app-based neuro-feedback system for drug-free ADHD treatment. Aziz Kaddan and Anas Abu Mukh were...
Business
– SuperCom Ltd., Alcobra Pharmaceuticals Ltd., and ReWalk Robotics Ltd. are seeking investments on NASDAQ. – SuperCom files for $50 million Nasdaq offering By...
Business
– – Israeli biomedical firms look back on a successful year on Wall Street. Are we bearing witness to “the new tech”? Will the...
Blogs
– In the 8th Dec 2013 edition of Israel’s good news: ECONOMY & BUSINESS Unemployment falls to 5.9%. Israel’s unemployment rate fell to...
IPOs
– CEO Ori Hadomi: The proceeds from the offering would be used to expand the company’s sales and marketing network in the US. –...
IPOs
– Enzymotec, which has developed a proprietary method for processing fatty acids, is seeking to raise $75 million. – – / By Gali Weinreb...